A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women.

[1]  C. Wolfe,et al.  Increased Common Carotid Intima-Media Thickness in UK African Caribbeans and Its Relation to Chronic Inflammation and Vascular Candidate Gene Polymorphisms , 2001, Stroke.

[2]  T. Lehtimäki,et al.  Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men. , 2001, Metabolism: clinical and experimental.

[3]  M. Bond,et al.  Site-Specific Atherosclerotic Plaques in the Carotid Arteries of Middle-Aged Women From Southern Italy: Associations With Traditional Risk Factors and Oxidation Markers , 2001, Stroke.

[4]  P. Durrington,et al.  Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  T. Lehtimäki,et al.  Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis. , 2001, Atherosclerosis.

[6]  G. Siest,et al.  APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima‐media thickness in healthy men (the Stanislas Cohort) , 2001, Clinical genetics.

[7]  P. Durrington,et al.  Paraoxonase and Atherosclerosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[8]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[9]  T. Lehtimäki,et al.  Lipid peroxidation is increased in paraoxonase L55 homozygotes compared with M-allele carriers , 2001, Free radical research.

[10]  A. Gardemann,et al.  The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. , 2000, Atherosclerosis.

[11]  H. Campos,et al.  Tobacco Smoking Modifies Association Between Gln-Arg192 Polymorphism of Human Paraoxonase Gene and Risk of Myocardial Infarction , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Aviram,et al.  Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. , 2000, Circulation.

[13]  Y. Yazaki,et al.  Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. , 2000, Atherosclerosis.

[14]  D. Knook,et al.  Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. , 2000, Atherosclerosis.

[15]  A. Zanchetti,et al.  Baseline reproducibility of B‐mode ultrasonic measurement of carotid artery intima – media thickness: the European Lacidipine Study on Atherosclerosis (ELSA) , 2000, Journal of hypertension.

[16]  A. Gnasso,et al.  Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population. , 1999, Coronary Artery Disease.

[17]  J. Kastelein,et al.  Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. , 1999, Atherosclerosis.

[18]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[19]  R. Schmidt,et al.  Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. , 1998, Stroke.

[20]  A. Montali,et al.  The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[21]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[22]  P. Durrington,et al.  Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification , 1998, FEBS letters.

[23]  D. Sanghera,et al.  The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese. , 1998, Atherosclerosis.

[24]  M. Jauhiainen,et al.  The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. , 1996, The Journal of clinical investigation.

[25]  B. La Du,et al.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. , 1996, Genomics.

[26]  R. Hegele,et al.  Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins , 1996, Current opinion in lipidology.

[27]  M. Bond,et al.  Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. , 1995, Circulation.

[28]  R. Dorizzi,et al.  Appearance of heavy chains and unfavorable prognosis in Hodgkin disease. , 1995, Clinical Chemistry.

[29]  A. Di Costanzo,et al.  Increased intima-media thickness of the common carotid artery in hypercholesterolemic children. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  C. Rice-Evans,et al.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. , 1993, Clinical science.

[31]  P. Muti,et al.  Progetto ATENA, A study on the etiology of major chronic diseases in women: Design, rationale and objectives , 1992, European Journal of Epidemiology.

[32]  D. Sanghera,et al.  DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. , 1998, American journal of human genetics.

[33]  P. Froguel,et al.  Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. , 1997, The Journal of clinical investigation.

[34]  P. Fürst,et al.  Improved analysis of malondialdehyde in human body fluids. , 1996, Free radical biology & medicine.

[35]  D. Adler,et al.  The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.